Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Depression During Buprenorphine Treatment
NCT00475878Phase 3Completed
- Sponsor
- Butler Hospital
- Start
- Dec 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Escitalopram oxalate oral solution in major depressive disorder (MDD), sponsored by Butler Hospital. Started Dec 2006; status: completed.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00475878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475878.